LifeStance Health Group, Inc.
LFST Healthcare Medical Care Facilities
LifeStance Health Group, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.4 billion, up 13.9% from fiscal 2024.
- Revenue
- +25.3%
- EPS
- +2,042.9%
- Free cash flow
- +31.6%
- Total debt
- −5.15%
Quarter to September 2026, against a year earlier
Follow LFST
Alert me
LifeStance Health Group, Inc. (LFST) EV/Sales
As of 5 November 2026, LifeStance Health Group, Inc. (LFST) trades at a EV/Sales of 3.1×. Over the past ten years it has ranged from 1.2× (August 2025) to 20.5× (June 2021); the current reading is higher than 67% of that period. That is above the Medical Care Facilities industry median of 1.4× and below the Healthcare sector median of 3.5×.
EV/Sales, daily
Embed this chart
Annual newest first
| Period | EV/Sales | Change |
|---|---|---|
| FY2025 | 1.9× | (17.73%) |
| FY2024 | 2.3× | (20.64%) |
| FY2023 | 2.9× | 42.93% |
| FY2022 | 2.1× | (56.09%) |
| FY2021 | 4.7× | (70.23%) |
| FY2020 | 15.7× | 0.00% |
| FY2019 | 15.7× | — |
Quarterly newest first
| Period | EV/Sales | Change |
|---|---|---|
| Sep 2026 | 2.8× | 5.52% |
| Jun 2026 | 2.6× | 54.08% |
| Mar 2026 | 1.7× | (11.69%) |
| Dec 2025 | 1.9× | 19.70% |
| 23 more quarters | Free account |
Against its own ten years
EV/Sales against peers
| Company | EV/Sales |
|---|---|
| OPCH Option Care Health, Inc. compare | 1.0× |
| PACS PACS Group, Inc. compare | 1.4× |
| ACHC Acadia Healthcare Company, Inc. compare | 1.6× |
| AVAH Aveanna Healthcare Holdings Inc. compare | 1.7× |
| NHC National HealthCare Corporation compare | 1.9× |
| SGRY Surgery Partners, Inc. compare | 1.9× |
| CHE Chemed Corporation compare | 2.7× |
| CON Concentra Group Holdings Parent, Inc. compare | 2.9× |
| LFST LifeStance Health Group, Inc. | 3.1× |
| Medical Care Facilities industry median | 1.4× |
| Healthcare sector median | 3.5× |
| Market median | 2.1× |
What EV/Sales is
EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)
More on LFST
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement